Evidence map›Paper›PMID 32759296›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

Ascorbic Acid Promotes

Cheng-Ying Wu, Bin Zhang, Hansol Kim, Stephen K Anderson, Jeffrey S Miller, Frank Cichocki

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Vγ9Vδ2 T cells expanded with vitamin C combined with HMBPPFrontiers in cellular and infection microbiology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Frontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cheng-Ying WuDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455; and.
Bin ZhangDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455; and.ORCID 0000-0003-1717-3218
Hansol KimDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455; and.ORCID 0000-0002-5046-8643
Stephen K AndersonBasic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702.ORCID 0000-0002-7856-4266
Jeffrey S MillerDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455; and.
Frank CichockiDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455; and cich0040@umn.edu.ORCID 0000-0003-3043-0653
University of Minnesota · USFrederick National Laboratory for Cancer Research · US

Funding

Trial Design and Biostatistical Support CoreP01CA065493 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1995 to 2026
$48.2M
Therapeutic Potential of Adaptive NK Cells in Cancer and TransplantationP01CA111412 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MILLER, JEFFREY S. · 2005 to 2025
$38.2M
Viral priming and targeting NK cells against solid tumor malignanciesR35CA197292 · NCI · UNIVERSITY OF MINNESOTA · PI MILLER, JEFFREY S. · 2015 to 2021
$6.2M
Molecular Programming of Immunological Memory in Human Natural Killer CellsR00HL123638 · NHLBI · UNIVERSITY OF MINNESOTA · PI CICHOCKI, FRANK · 2017 to 2019
$736k
Molecular Programming of Immunological Memory in Human Natural Killer CellsK99HL123638 · NHLBI · UNIVERSITY OF MINNESOTA · PI CICHOCKI, FRANK · 2015 to 2016
$190k
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCI NIH HHS P01 CA065493NCI NIH HHS P01 CA111412NCI NIH HHS R35 CA197292NHLBI NIH HHS K99 HL123638NHLBI NIH HHS R00 HL123638
6 · The paper itself

Abstract

Variegated expression of killer Ig-like receptors (KIR) in human NK cells is a stochastic process exclusive to subsets of mature NK cells and CD8

Indexed as

Ascorbic AcidCD56 AntigenCell DifferentiationCells, CulturedCore Binding Factor Alpha 3 SubunitDemethylationDioxygenasesDNA-Binding ProteinsDNA MethylationGene Expression RegulationHumansKiller Cells, NaturalLymphocyte ActivationPromoter Regions, GeneticProto-Oncogene ProteinsReceptors, KIRAscorbic AcidCD56 AntigenCore Binding Factor Alpha 3 SubunitDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsReceptors, KIRTET2 protein, humanTET3 protein, human

Identifiers

PMID32759296
PMCPMC7484163
OpenAlexW3047401467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.